Nonspecific radiographic manifestations of cytomegalovirus infection in 4 HIV-positive adults – diagnosis through transbronchial biopsy by Goodier, M & Rubin, G
A PR I L  2 0 1 1                                    T H E  S O U T H E R N  A F R I C A N  J O U R NA L  O F  H I V  M E D I C I N E
CASE 1
A 45-year-old man with a history of previous tuberculosis 
(TB) infection presented with a cough and chest pain. 
Sputum results and blood cultures were negative. The 
chest radiograph (CXR) demonstrated bilateral multifocal 
areas of patchy airspace disease, as well as a dominant 
focal area of density in the right upper lobe (Fig. 1). No 
effusions were noted. A presumed diagnosis of PJP 
was made, but the patient did not respond to treatment. 
Bronchoscopic biopsy confirmed CMV infection. 
CASE 2
A 43-year-old woman with no history of TB or TB contacts 
presented with a cough and haemoptysis, loss of weight, 
low fever and rigors. The white cell count (WCC) was 
6.4×109/l, and sputum results and blood cultures were 
negative. The CXR revealed bilateral reticular-nodular 
and ground-glass opacities without any effusions (Fig. 
2, a). The differential diagnosis included TB and PJP. 
Bronchoscopic biopsy confirmed the diagnosis of both 
CMV and PJP infections. 
CASE 3
A 30-year-old woman presented with shortness of 
breath, a dry cough, loss of weight and fever. The 
WCC was 13×109/l and the CD4 count 481 cells/µl. The 
CXR demonstrated bilateral reticular and ground-glass 
opacities (Fig. 2, b). Treatment for TB and PJP was 
started, but the patient showed no clinical improvement. 
Bronchoscopic biopsy confirmed both CMV and 
pneumocystis pneumonia (PCP).
CASE 4
A 29-year-old woman presented with a cough, chest pain, 
loss of weight and shortness of breath. The WCC was 
9.1×109/l and the CD4 count 14 cells/µl. On the CXR there 
were bilateral, diffuse, reticular and airspace shadows 
with no effusions (Fig. 2, c). Both TB and PJP were 
considered in the differential diagnosis. Transbronchial 
biopsy revealed CMV and PJP infections.
Transbronchial biopsy in all patients demonstrated 
alveolar tissue containing CMV with nuclear and 
cytoplasmic inclusions (Fig. 3). This was accompanied 
by alveolitis and an associated inflammatory cell infiltrate 
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We report on 4 HIV-positive adult patients who presented (over a 2-year period) with clinically significant cytome-
galovirus (CMV) pneumonia requiring transbronchial biopsy for diagnosis. The patients were not on antiretroviral 
therapy. Clinical findings were nonspecific, sputum samples were negative, blood test results were non-contributo-
ry, and empirical treatment had failed. Radiological findings were extensive but nonspecific. Three of the 4 patients 
were co-infected with Pneumocystis jirovecii (PJP) pneumonia, further confounding the radiological diagnosis. 
Fig. 1. The chest radiograph in patient 1 demonstrates 
bilateral multifocal areas of patchy airspace disease, as well 
as a dominant focal area of density in the right upper lobe.
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of the alveolar walls. Ziehl-Neelsen staining and culture 
for TB were negative in all patients.
DISCUSSION 
CMV is a relatively commonly identified pathogen in 
immunocompromised patients. This was first recognised 
in patients on immunosuppressive therapy for 
haematological malignancies or bone marrow and other 
organ transplants. In the South African setting, most CMV 
infections occur in patients with HIV/AIDS. CMV disease 
usually occurs in patients with low CD4 counts (<100 
cells/µl).1 Disseminated infection is relatively common 
and may manifest clinically as retinitis, encephalitis, 
hepatitis, oesophagitis or colitis. Clinically significant 
pulmonary infection is uncommon. However, CMV may 
be isolated in more than half of broncho-alveolar lavage 
(BAL) specimens in AIDS patients with pulmonary 
symptoms.2 
In most patients, CMV infection co-exists with other 
opportunistic infections, particularly PCP. In this setting, 
there is doubt regarding to what extent CMV is acting 
as a pathogen.3 The diagnosis of CMV pneumonitis is 
therefore often based on typical symptoms of fever, 
shortness of breath, hypoxaemia and diffuse infiltrates 
on the CXR in combination with detection of the virus 
in BAL fluid and the absence of other pathogens.4 
However, because of the high rates of co-infection, a 
definitive diagnosis of CMV requires identification of 
CMV intranuclear or cytoplasmic inclusion bodies in 
transbronchial biopsy specimens (used in our patients) 
or open lung biopsy specimens.5  
Routinely securing a tissue diagnosis in the local setting 
is impractical and may be dangerous in patients with 
certain conditions, e.g. thrombocytopenia.4 In one 
study examining AIDS patients undergoing diagnostic 
bronchoscopy for pulmonary symptoms, 72% had CMV 
cultured from BAL fluid but only 2 had pathological 
Fig. 2, a - c. In the chest radiographs of patients 2, 3 and 
4, nonspecific bilateral reticular-nodular and ground-glass 




Fig. 3. Haematoxylin and eosin, high power. A = enlarged 
alveolar pneumocyte with brick-red intranuclear CMV 
inclusion body; B = alveolar space; C = alveolar wall showing 
a nonspecific inflammatory cell infiltrate. (Acknowledgement: 
Jill Murray, School of Public Health, University of the 
Witwatersrand and National Health Laboratory Service.)
35
A PR I L  2 0 1 1                                    T H E  S O U T H E R N  A F R I C A N  J O U R NA L  O F  H I V  M E D I C I N E
evidence of CMV pneumonitis. Only 1 of these patients 
had autopsy confirmation that the cause of death was 
CMV pneumonitis.6 In practice, treatment is therefore 
usually aimed at all other organisms, and only if the 
patient does not improve is anti-CMV therapy initiated.
In patients with pathologically proven CMV pneumonia, 
CXRs usually show bilateral, reticular, interstitial disease 
that classically begins in the periphery of the lower 
lobes and spreads centrally and superiorly, as seen in 
3 of our patients. Focal infiltrates, nodules and diffuse 
alveolar infiltrates are less common findings and were 
noted in 2 of our patients.7 Because of the nonspecific 
clinical presentation, clinicians tend to rely on imaging to 
distinguish between CMV and PJP. However, it is usually 
impossible to differentiate between these two conditions 
on the basis of radiographic findings. In this context 
some consider thin-section computed tomography (CT) 
to be the investigation of choice.1 CT scans may reveal 
bilateral or focal ground-glass or consolidative changes, 
as well as (less commonly) well-defined solitary or 
multiple nodules measuring up to 3 cm in diameter,8 
which makes CT also poor at differentiating between PCP 
and CMV infection. In a study comparing CT findings 
in these two infections in 58 immunocompromised HIV-
negative patients, small and centrilobular nodules, 
unsharp demarcation of the ground-glass infiltrates and 
consolidation favoured CMV pneumonia, while an apical 
distribution and the occurrence of a mosaic pattern 
suggested PCP.1 Although CMV usually mimics PCP, the 
radiological differential diagnosis of diffuse interstitial 
pulmonary infiltrates in AIDS also includes infections 
with other organisms.
ConClusion
Even though CMV is a relatively commonly identified 
organism in BAL specimens from immunocompromised 
HIV patients, CMV pneumonia is uncommon. As 
demonstrated in our patients, CMV pneumonitis typically 
has a nonspecific plain radiographic presentation which 
overlaps with that of PCP, a common co-infection. The 
diagnosis then relies on transbronchial biopsy. In sub-
Saharan Africa, where a large proportion of patients 
are not yet on antiretroviral therapy and have low CD4 
counts, CMV remains an important differential diagnosis 
in pneumonia in HIV/AIDS. Where there are resource 
limitations for performing bronchoscopic biopsy, failure 
of a trial of therapy and diffuse interstitial or patchy 
airspace disease on CXR should prompt the clinician to 
initiate treatment for CMV.
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